ADVERTISEMENT
Advertise

Content

List volumes - List articles in this issue

Clinical Report

Long-term Follow-up of In situ Extramammary Paget’s Disease in Asian Skin Types IV/V Treated with Photodynamic Therapy

doi: 10.2340/00015555-0818

Abstract:

Photodynamic therapy is a potentially advantageous treatment for non-melanoma skin cancers. We evaluated the clinical response, recurrence and adverse events of photodynamic therapy for in situ extramammary Paget’s disease in 14 male and 3 female Chinese patients with 21 lesions. Topical 20% 5-aminolevulinic acid was applied for 6 h. Each lesion was irradiated with 633 nm red light three times, 1 week apart, at a total dose of 339 J/cm2, followed by three assessments at 6, 12 and 24 months. Overall complete response (CR) rates were 52.4%, 42.9%, and 33.3% at 6, 12 and 24 months, respectively. The CR rate was significantly higher in scrotal lesions (66.6%) than in non-scrotal lesions (8.3%). The overall recurrence rate was 50%. The highest CR rate was for the lesions < 4 cm in diameter (62.5%), followed by those 4–8 cm (33.3%) and > 8 cm (0%). Most adverse events were well tolerated. In conclusion, photodynamic therapy for extramammary Paget’s disease is not recommended as the first option except for scrotal cases or lesions < 4 cm in diameter.

Authors:

Qiang Li, Tianwen Gao, Bin Jiao, Xianlong Qi, Heather Ann Long, Hongjiang Qiao, Lei Wang, Yajie Lv, Xuehui Hu, Wenjun Liao, Shengchun Wang, Chunying Li

References

  • McCarter MD, Quan SH, Busam K, Paty PP, Wong D, Guillem JG. Long-term outcome of perianal Paget’s disease. Dis Colon Rectum 2003; 46: 612–616.
  • Salamanca J, Benito A, Garcia-Penalver C, Azorin D, Ballestin C, Rodriguez-Peralto JL. Paget’s disease of the glans penis secondary to transitional cell carcinoma of the bladder: a report of two cases and review of the literature. J Cutan Pathol 2004; 31: 341–345.
  • Siesling S, Elferink MA, van Dijck JA, Pierie JP, Blokx WA. Epidemiology and treatment of extramammary Paget disease in the Netherlands. Eur J Surg Oncol 2007; 33: 951–955.
  • Chang YT, Liu HN, Wong CK. Extramammary Paget’s disease: a report of 22 cases in Chinese males. J Dermatol 1996; 23: 320–324.
  • Fanning J, Lambert HC, Hale TM, Morris PC, Schuerch C. Paget’s disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget’s disease, and recurrence after surgical excision. Am J Obstet Gynecol 1999; 180: 24–27.
  • Zollo JD, Zeitouni NC. The Roswell Park Cancer Institute experience with extramammary Paget’s disease. Br J Dermatol 2000; 142: 59–65.
  • Hendi A, Brodland DG, Zitelli JA. Extramammary Paget’s disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol 2004; 51: 767–773.
  • Becker-Wegerich PM, Fritsch C, Schulte KW, Megahed M, Neuse W, Goerz G, et al. Carbon dioxide laser treatment of extramammary Paget’s disease guided by photodynamic diagnosis. Br J Dermatol 1998; 138: 169–172.
  • Moreno-Arias GA, Conill C, Castells-Mas A, Arenas M, Grimalt R. Radiotherapy for genital extramammary Paget’s disease in situ. Dermatol Surg 2001; 27: 587–590.
  • Fujisawa Y, Umebayashi Y, Otsuka F. Metastatic extramammary Paget’s disease successfully controlled with tumour dormancy therapy using docetaxel. Br J Dermatol 2006; 154: 375–376.
  • Cohen PR, Schulze KE, Tschen JA, Hetherington GW, Nelson BR. Treatment of extramammary Paget disease with topical imiquimod cream: case report and literature review. South Med J 2006; 99: 396–402.
  • Wang LC, Blanchard A, Judge DE, Lorincz AA, Medenica MM, Busbey S. Successful treatment of recurrent extramammary Paget’s disease of the vulva with topical imiquimod 5% cream. J Am Acad Dermatol 2003; 49: 769–772.
  • Yeh MH, Hu SL. Treatment of double ectopic extramammary Paget’s disease of bilateral chest with imiquimod 5% cream. J Eur Acad Dermatol Venereol 2007; 21: 997–999.
  • Kennedy JC, Marcus SL, Pottier RH. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. J Clin Laser Med Surg 1996; 14: 289–304.
  • Shieh S, Dee AS, Cheney RT, Frawley NP, Zeitouni NC, Oseroff AR. Photodynamic therapy for the treatment of extramammary Paget’s disease. Br J Dermatol 2002; 146: 1000–1005.
  • Calzavara-Pinton PG, Venturini M, Sala R, Capezzera R, Parrinello G, Specchia C, et al. Methylaminolaevulinate-based photodynamic therapy of Bowen’s disease and squamous cell carcinoma. Br J Dermatol 2008; 159: 137–144.
  • Horn M, Wolf P, Wulf HC, Warloe T, Fritsch C, Rhodes LE, et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003; 149: 1242–1249.
  • Raspagliesi F, Fontanelli R, Rossi G, Ditto A, Solima E, Hanozet F, et al. Photodynamic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget’s disease of the vulva: a pilot study. Gynecol Oncol 2006; 103: 581–586.
  • Fukui T, Watanabe D, Tamada Y, Matsumoto Y. Photodynamic therapy following carbon dioxide laser enhances efficacy in the treatment of extramammary Paget’s disease. Acta Derm Venereol 2009; 89: 150–154.
  • Bird SB, Dickson EW. Clinically significant changes in pain along the visual analog scale. Ann Emerg Med 2001; 38: 639–643.
  • National Cancer Institute. National Cancer Institue Common Toxicity Criteria.Version 2.0. Bethesda, MD: National Cancer Institue; 1999.
  • Ho SG, Chan HH. The Asian dermatologic patient: review of common pigmentary disorders and cutaneous diseases. Am J Clin Dermatol 2009; 10: 153–168.
  • Lloyd J, Flanagan AM. Mammary and extramammary Paget’s disease. J Clin Pathol 2000; 53: 742–749.
  • Szeimies RM, Morton CA, Sidoroff A, Braathen LR. Photodynamic therapy for non-melanoma skin cancer. Acta Derm Venereol 2005; 85: 483–490.
  • Henderson BW, Busch TM, Vaughan LA, Frawley NP, Babich D, Sosa TA, et al. Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. Cancer Res 2000; 60: 525–529.
  • Madan V, Lancaster J, Allan D, Lear J, Sheridan L, Leach C, Allan E. Extramammary Paget’s disease treated with topical and systemic photodynamic therapy. Photodiag Photodyn Ther 2005; 2: 3.
  • Related articles

    There are no related articles.


    Share with your friends





    Actions


    Abstract

    Full text

    PDF

    Supplementary


    There is no supplementary for this article.

    Print information


    Volume 90, Issue 2

    DOI: 10.2340/00015555-0818

    Pages: 159-164

    View at PubMed